Foresight Group has made a £1.25 million growth capital investment into Fertility Focus Limited, a leading fertility monitoring technology company that has developed OvuSense, a registered medical device that enables women to predict ovulation.  The investment was led by Foresight on behalf of Foresight VCT plc and Foresight 4 VCT plc as part of a larger £2 million funding round, supported by new and existing investors including private High Net-Worth Individuals.